Skip to main content
OpenTrials
Completed

NCT Number: NCT07049250

Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients

This study investigates the effect of an evidence-based nursing intervention, guided by a quantitative evaluation strategy, on psychological resilience and illness perception in lung cancer patients undergoing chemotherapy. Patients were randomized to receive either the specialized nursing intervention or routine nursing care, with outcomes assessed at baseline and 3 months post-intervention.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The First Hospital of Hebei Medical University

Shijiazhuang, Hebei, 050000, China

About this study

Lung cancer patients undergoing chemotherapy often experience significant physical and psychological distress. Conventional nursing may not adequately address these multifaceted needs. Evidence-based nursing (EBN) integrates research evidence, clinical expertise, and patient preferences. This study evaluated an EBN intervention model guided by a quantitative evaluation strategy, which involves multidisciplinary risk assessment, tailored interventions including psychological support, cognitive restructuring, and complication prevention. The study aimed to determine if this model could improve psychological resilience, illness perception, coping styles, and reduce chemotherapy-related complications in lung cancer patients compared to routine nursing care. A total of 142 patients were randomized. The intervention group received a comprehensive EBN program including risk stratification, psychological/cognitive interventions (e.g., cognitive-behavioral techniques, peer mentoring, family counseling), systematic complication prevention (e.g., prophylactic antiemetics, dietary guidance, infection control), and sleep optimization. The control group received standard disease education, exercise guidance, and medication adherence counseling. Outcomes were measured at baseline and 3 months post-intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of lung cancer confirmed according to the Chinese Quality Control Indicators for Standardized Diagnosis and Treatment of Primary Lung Cancer (2022) through both imaging and histopathological examination.
  • TNM staging determined using the 8th edition AJCC/UICC classification system.
  • Scheduled to receive chemotherapy with an expected survival exceeding one year.
  • Demonstrated normal cognitive and communication abilities as assessed by standardized neuropsychological tests.
  • Provided written informed consent prior to enrollment.

Exclusion criteria

  • Pre-existing neurological disorders.
  • Significant organ dysfunction (defined as Child-Pugh class B/C for liver function or eGFR <30 mL/min/1.73m² for renal function).
  • Active infectious diseases.
  • Contraindications to chemotherapy.
  • Concurrent radiotherapy.

Treatment and study plan

Evidence-Based Nursing Intervention under Quantitative Evaluation Strategy

Behavioral

A multifaceted nursing program incorporating comprehensive risk assessment, dynamic risk stratification, psychological and cognitive interventions (including cognitive-behavioral techniques, peer mentoring, family counseling), systematic complication prevention strategies (including prophylactic antiemetics, dietary guidance, infection control), and sleep optimization protocols.

Routine Nursing Care

Behavioral

Standard disease education on chemotherapy side effects and self-management, personalized exercise guidance, and medication adherence counseling. Delivered in 30-minute sessions twice weekly for two months.

Primary outcomes

  1. Change in Psychological Resilience Score

    Time frame: Baseline and 3 months post-intervention.

    Psychological resilience assessed using the 25-item Resilience Scale. Scores range from 0 to 100, with higher scores indicating better psychological resilience. The scale measures optimism, resilience, and strength subdomains.

Secondary outcomes

  1. Change in Illness Perception

    Time frame: Baseline and 3 months post-intervention.

    Illness perception assessed using the Brief Illness Perception Questionnaire (B-IPQ). This evaluates emotional, cognitive, and comprehension domains, with each item scored from 0 to 10. Higher scores in relevant domains indicate more positive or accurate illness perception.

  2. Change in Coping Styles

    Time frame: Baseline and 3 months post-intervention.

    Coping styles measured by the Simplified Coping Style Questionnaire (SCSQ) to distinguish between active and passive coping strategies. Higher scores for active coping and lower scores for passive coping are generally considered favorable.

  3. Incidence of Chemotherapy-Related Complications

    Time frame: Assessed throughout the 3-month post-intervention period.

    Occurrence of chemotherapy-related complications including gastrointestinal reactions, pulmonary infections, hepatorenal toxicity, bone marrow suppression, and phlebitis. Assessed as percentage of patients experiencing each complication.

Sponsors and collaborators

Lead sponsor

The First Hospital of Hebei Medical University

Other

Registry information

Official study title

Effect of Evidence-Based Nursing Intervention Under Quantitative Evaluation Strategy on Psychological Resilience and Illness Perception in Lung Cancer Patients Undergoing Chemotherapy

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 3, 2025
Registry last updated
Jul 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.